Healthcare

The treatment of rare diseases requires the use of specialized drugs. Patient populations for rare diseases are most often quite small, consequently the products treating them earn the designation orphan drugs. These drugs must undergo the research, development, and clinical trials that all drugs do, yet the investment into the development is great...

Given the ever increasing cost of care, healthcare delivery is moving towards decentralisation. Service delivery from healthcare settings such as mobile clinics, rapid retail clinics, and home settings demands the use of new-age clinical laboratory diagnostics. The effective delivery of healthcare services has created a business and technology conv...

The study contains data about three major segments in the Percutaneous Coronary Interventional (PCI) market in the Association of Southeast Asian Nations (ASEAN) market, which are coronary stents, consumables, and embolic protection devices. Cardiac devices are conventionally developed to address major cardiac ailments such as heart blocks. They ar...

This research traces the history of the first clinical applications for robotic devices and all associated technology required to create a true robotic-assisted surgical device (RASD). The study examines the people (leaders) and entities that became pioneers and founders of the RASD industry vertical. With fundamental original equipment manufacture...

09 Nov 2016  |  North America  |  Market Research

New Paradigms Driving Digital Health Deals and Partnerships

Healthcare Transformation and Industry Convergence

Infographics

×

Digital technologies are critical enablers of healthcare transformation but organizations vary greatly in their capabilities to deliver new solutions needed to capture growing market opportunities. The imperative to rapidly bring on new IT capabilities as well as to continually adapt and innovate in a highly dynamic environment is driving a wide ar...

The US molecular diagnostics market is growing at 12.5% CAGR and is set to reach close to $6.5 billion by 2021. PCR, next-generation sequencing (NGS), microarray, and fluorescent in situ-hybridization (FISH) are the dominant technologies in this space with PCR holding more than 75% of the market. Roche, Cepheid, Qiagen, Abbott, and Thermo Fisher do...

04 Nov 2016  |  North America  |  Market Research

Vision 2025 - The Future of Healthcare

Projecting Market Transformations and Growth Opportunities

Infographics

×

Global healthcare trends of aging populations, rising chronic disease prevalence, and urbanization are bound to further strain healthcare systems already grappling with issues of healthcare access, quality, and cost. New treatment paradigms are required that integrate elements of prediction, prevention, and automation to make care more affordable a...

Acquired by Google in 2014, DeepMind is leveraging artificial intelligence-based machine learning technology to solve some of the biggest problems in healthcare such as early diagnosis of life-threatening conditions including cancer and diabetes. DeepMind is partnering with NHS at various levels to address healthcare issues. This includes patient d...

30 Sep 2016  |  North America  |  Market Research

US mHealth Market and Growth Opportunity Analysis

Mobile Services Shifting to Care and Case Management

Infographics

×

mHealth is one of the most talked about subjects in healthcare, yet it has struggled from a business model standpoint, market scalability, and general over-hype. It is currently observed that there are low barriers to entry and it is not a sure thing that established market leaders can sustain their position as new entrants or disruptive solutions ...